CONMED (NYSE:CNMD) Given New $58.00 Price Target at JPMorgan Chase & Co.
CONMED (NYSE:CNMD – Get Free Report) had its price objective dropped by JPMorgan Chase & Co. from $70.00 to $58.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 0.83% from the company’s current […]
CONMED (NYSE:CNMD – Get Free Report) had its price objective dropped by JPMorgan Chase & Co. from $70.00 to $58.00 in a research report issued on Thursday,Benzinga reports. The brokerage currently has a “neutral” rating on the stock. JPMorgan Chase & Co.‘s price target would suggest a potential upside of 0.83% from the company’s current […]
